Labcorp declares quarterly dividend

BURLINGTON, N.C. , April 6, 2023 /PRNewswire/ -- Labcorp  (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 8, 2023 , to stockholders of record as of

Labcorp expands access to colorectal cancer screening through partnership with the Conference of National Black Churches

Partnership will distribute screening kits to communities at higher risk of colon cancer BURLINGTON, N.C. , April 3, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, is partnering with the Conference of National Black Churches (CNBC) to address health equity gaps in

Labcorp announces 2022 Corporate Responsibility Report

Every day, millions of people count on Labcorp to help them better understand their healthcare needs, and we take that responsibility very seriously. As a leading global life sciences company, we recognize that we also have a tremendous responsibility to demonstrate progress on important environmental, social and governance (ESG) efforts, and to make a positive impact for the patients, providers, consumers and business leaders who rely on us.

Labcorp to announce first quarter financial results on April 25, 2023

BURLINGTON, N.C., March 31, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the first quarter of 2023 before the market opens on Tuesday, April 25, 2023 . The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

Lab stewardship program reduces unnecessary costs and improves patient care

A large, Chicago-based FQHC network wanted to optimize efficiency of testing, improve patient care and provide better, more accurate testing for their highrisk population, while also eliminating unnecessary testing expenses. The network, however, faced a lack of population health analytics tools and limited funding to invest in developing their own.

Using clinical lab data to improve diabetes outcomes in underserved populations

More than 37 million Americans (more than 11% of the population) have diabetes.1 This statistic alone highlights the need to improve patient care, especially in underserved populations where incidence of the disease is high.